Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | INPPL1 | O15357 | 2/20 | 0.32 |
| ▸ | INPP5A | Q14642 | 2/20 | 0.32 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.32 |
| ▸ | INPP5B | P32019 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | ITPR3 | Q14573 | 3/20 | 0.30 |
| ▸ | ITPR2 | Q14571 | 1/20 | 0.30 |
| ▸ | ITPR1 | Q14643 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18831791 | 0.81 | — | — | |
| SCHEMBL3079946 | 0.81 | ALDH1A1 (0.33) | FDPSBLMTDP1 | |
| SCHEMBL1502473 | 0.72 | — | — | |
| SCHEMBL6279518 | 0.72 | — | — | |
| SCHEMBL8377664 | 0.72 | — | — | |
| SCHEMBL25432405 | 0.72 | — | — | |
| Hydrochloric Acid SCHEMBL10613713 | 0.69 | — | — | |
| Hydrochloric Acid SCHEMBL11213557 | 0.69 | — | — | |
| Pyrophosphoric Acid SCHEMBL8851914 | 0.61 | FDPS (1.00) | FDPSBLMTDP1CA4INPPL1 | |
| Pyrophosphoric Acid SCHEMBL292348 | 0.61 | FDPS (1.00) | FDPSBLMTDP1CA4INPPL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023217708-A1 | PHOSPHORUS-31 MRI AGENTS | UNIVERSITEIT TWENTE (NL) | 2023-11-16 | — | — | WO | claimed |
| WO-2023217708-A1 | PHOSPHORUS-31 MRI AGENTS | UNIVERSITEIT TWENTE (NL) | 2023-11-16 | — | — | WO | disclosed |
| WO-2023217708-A1 | PHOSPHORUS-31 MRI AGENTS | UNIVERSITEIT TWENTE (NL) | 2023-11-16 | — | — | WO | disclosed |
| CN-109890831-A | Substituted nucleosides, nucleotide and their analog | 詹森生物制药有限公司 | 2019-06-14 | — | — | CN | disclosed |
| CN-109843302-A | Compounds, compositions and methods for treating diseases | 斯必乐维生物科学公司 | 2019-06-04 | — | — | CN | disclosed |
| CN-104694628-B | Using the activated polymerization nucleic acid reacted by polyphosphoric acid decomposition (APP) | 生命技术公司 | 2017-06-06 | — | — | CN | disclosed |
| US-8399196-B2 | Nucleic acid sequencing methods, kits and reagents | GENEFORM TECHNOLOGIES LIMITED (GB) | 2013-03-19 | — | — | US | disclosed |
| EP-1594987-B1 | NUCLEIC ACID SEQUENCING METHODS, KITS AND REAGENTS | GENEFORM TECHNOLOGIES LTD (GB) | 2009-05-27 | — | — | EP | disclosed |
| US-20070148645-A1 | Nucleic acid sequencing methods, kits and reagents | GENEFORM TECHNOLOGIES LIMITED (GB) | 2007-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070148645-A1 | Nucleic acid sequencing methods, kits and reagents | UNG, DNTT, RNGTT | FDPS 964/4885BLM 296/4885TDP1 80/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.